Zydus Lifesciences Limited (ZYDUSLIFE) — Strategic Asset Allocation Index
Zydus Lifesciences Limited (ZYDUSLIFE) has a Strategic Asset Allocation Index of 35.8% as of September 2022. Strategic assets (PP&E of Rs67.22 Billion plus long-term investments of Rs-) total Rs67.22 Billion, measured against net assets of Rs187.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Zydus Lifesciences Limited Strategic Asset Allocation Index (2020–2022)
This chart shows how Zydus Lifesciences Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 35.8%, representing strategic assets of Rs67.22 Billion against net assets of Rs187.68 Billion INR. Explore ZYDUSLIFE operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Zydus Lifesciences Limited (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zydus Lifesciences Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zydus Lifesciences Limited stock valuation.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.7% | Rs64.23 Billion | Rs64.23 Billion | Rs- | Rs190.54 Billion | ▼ -8.7 pp |
| 2021 | 42.4% | Rs63.33 Billion | Rs63.33 Billion | Rs- | Rs149.30 Billion | ▼ -10.5 pp |
| 2020 | 52.9% | Rs61.94 Billion | Rs61.94 Billion | Rs- | Rs117.10 Billion | — |